D
Arch Biopartners Inc. ARCH.V
TSX
Recommendation
Sell
Prev Close
$1.78
Volume
--
Avg Vol (90D)
9,913
Market Cap
$82.98M
Dividend & Yield
--
52-Week Range
$1.36 - $2.41
P/E (TTM)
--
EPS (TTM)
-$0.0418
My Lists My Alerts
Weiss Ratings ARCH.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Rating D
Reward Index Very Weak
Risk Index Weak
Risk Grade D
Reward Grade E
Rating Factors ARCH.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Dividend Index --
Growth Index Weak
Efficiency Index Very Weak
Solvency Index Weak
Total Return Index Weak
Volatility Index Weak
Beta / Standard Deviation ARCH.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Beta 0.71
Price History ARCH.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
7-Day Total Return 2.19%
30-Day Total Return -1.58%
60-Day Total Return -3.11%
90-Day Total Return -4.59%
Year to Date Total Return -3.61%
1-Year Total Return -21.10%
2-Year Total Return -16.89%
3-Year Total Return -54.94%
5-Year Total Return 103.26%
52-Week High % Change -26.14%
52-Week Low % Change 30.88%
Price ARCH.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
52-Week High Price $2.41
52-Week Low Price $1.36
52-Week Low Price (Date) Aug 26, 2024
52-Week High Price (Date) Apr 04, 2024
Valuation ARCH.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Market Cap 82.98M
Enterprise Value 85.22M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.04
Earnings Per Share Growth 80.17%
Price/Earnings To Growth --
Price/Sales (TTM) 80.54
Price/Book (Q) -39.04
Enterprise Value/Revenue (TTM) 59.18
Price $1.87
Enterprise Value/EBITDA (TTM) --
Enterprise Value/EBIT -38.42
Market Cap Category Micro Cap
Dividends and Shares ARCH.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Shares Outstanding 64.94M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info ARCH.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Phone Number 647-428-7031
Address 545 King Street West Toronto, ON M5V 1M1
Website www.archbiopartners.com
Country Canada
Year Founded --
Profitability ARCH.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Operating Margin (TTM) -154.04%
Profit Margin -180.90%
Management Effectiveness ARCH.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Return on Assets -325.13%
Return on Equity --
Income Statement ARCH.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Revenue (TTM) 1.44M
Total Revenue (TTM) 1.44M
Revenue Per Share $0.02
Gross Profit (TTM) -1.30M
EBITDA (TTM) --
EBIT (TTM) -2.22M
Net Income (TTM) -2.61M
Net Income Avl. to Common (TTM) -2.61M
Total Revenue Growth (Q YOY) -61.57%
Earnings Growth (Q YOY) 48.34%
EPS Diluted (TTM) -0.04
EPS Diluted Growth (Q YOY) 50.00%
Balance Sheet ARCH.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash and Short-Term Inv. (Q) 38.10K
Cash Per Share (Q) $0.00
Total Current Assets (Q) 370.80K
Total Preferred Equity (Q) --
Total Equity (Q) -2.96M
Current Ratio (Q) 0.111
Book Value Per Share (Q) -$0.05
Total Assets (Q) 370.80K
Total Current Liabilities (Q) 3.33M
Total Debt (Q) 2.28M
Total Liabilities (Q) 3.33M
Total Common Equity (Q) -2.96M
Cash Flow ARCH.V - TSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash from Investing (TTM) --
Cash from Financing (TTM) 1.82M
Net Change in Cash (TTM) -185.20K
Levered Free Cash Flow (TTM) -1.26M
Cash from Operations (TTM) -2.00M
Weiss Ratings